News Sentiment

ACIU sentiment intelligence

AC Immune Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.39 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-4.8% over one week, +3.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -4.8% Price reacting lower
Trend fit Trend inactive 3.5% over four weeks
Fair value -18.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 33
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 10
TradingView 10
Seeking Alpha 3
Investing.com 2
MT Newswires 2
TradingKey 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 16
Deals and strategy 2
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
Zacks Investment Research Direct company coverage

Should I buy AC Immune (ACIU)

Tone
Positive 66/100
Event
Market update
Published
21 Oct 2016 11:05
Source
Zacks Investment Research